Petar Vukovic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Petar Vukovic has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Ivan Stojanovic
Department of Cardiac Surgery, Dedinje Cardiovascular Institute, Belgrade, Serbia
4 shared publicationsMiodrag Peric
Cardiovascular Institute Dedinje Belgrade , Belgrade
4 shared publications- Slobodan Micovic
Dedinje Cardiovascular Institute, 11000 Belgrade, Serbia
4 shared publications Miroslav Milicic
Department of Cardiac Surgery, Dedinje Cardiovascular Institute, Belgrade, Serbia
3 shared publicationsPredrag Milojevic
Department of Cardiac Surgery, Dedinje Cardiovascular Institute, Belgrade, Serbia
3 shared publicationsDragana Kosevic
Cardiovascular Institute Dedinje Belgrade , Belgrade
2 shared publications
Latest Publications
- Open Access
- 9 February 2021
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 8 (2) , 962-970
Cardio-Microcurrent Device for Chronic Heart Failure: First-in-Human Clinical Study
Aims Most devices for treating ambulatory Class II and III heart failure are linked to electrical pulses. However, a steady electric potential gradient is also necessary for appropriate myocardial performance and may be disturbed by structural heart diseases. We investigated whether chronic application of electrical microcurrent to the heart is feasible and safe and improves cardiac performance. The results of this study should provide guidance for the design of a two‐arm, randomized, controlled Phase II trial. Methods and results This single‐arm, non‐randomized pilot study involved 10 patients (9 men; mean age, 62 ± 12 years) at two sites with 6 month follow‐up. All patients had New York Heart Association (NYHA) Class III heart failure and non‐ischaemic dilated cardiomyopathy, with left ventricular ejection fraction (LVEF) P < 0.005) was present with improvements in LVEF, left ventricular end‐diastolic diameter, left ventricular end‐systolic diameter, and distance walked. For eight patients, NYHA classification improved from Class III to Class I (for seven, as early as 14 days post‐operatively); for one, to Class II; and for one, to Class II/III. 36‐Item Short‐Form Health Survey questionnaire scores also improved highly significantly. Conclusions Chronic application of microcurrent to the heart is feasible and safe and leads to a rapid and lasting improvement in heart function and a near normalization of heart size within days. The NYHA classification and quality of life improve just as rapidly.
- 9 February 2021
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 8 (2) , 962-970
Open AccessCardio-Microcurrent Device for Chronic Heart Failure: First-in-Human Clinical Study
Aims Most devices for treating ambulatory Class II and III heart failure are linked to electrical pulses. However, a steady electric potential gradient is also necessary for appropriate myocardial performance and may be disturbed by structural heart diseases. We investigated whether chronic application of electrical microcurrent to the heart is feasible and safe and improves cardiac performance. The results of this study should provide guidance for the design of a two‐arm, randomized, controlled Phase II trial. Methods and results This single‐arm, non‐randomized pilot study involved 10 patients (9 men; mean age, 62 ± 12 years) at two sites with 6 month follow‐up. All patients had New York Heart Association (NYHA) Class III heart failure and non‐ischaemic dilated cardiomyopathy, with left ventricular ejection fraction (LVEF) P < 0.005) was present with improvements in LVEF, left ventricular end‐diastolic diameter, left ventricular end‐systolic diameter, and distance walked. For eight patients, NYHA classification improved from Class III to Class I (for seven, as early as 14 days post‐operatively); for one, to Class II; and for one, to Class II/III. 36‐Item Short‐Form Health Survey questionnaire scores also improved highly significantly. Conclusions Chronic application of microcurrent to the heart is feasible and safe and leads to a rapid and lasting improvement in heart function and a near normalization of heart size within days. The NYHA classification and quality of life improve just as rapidly.
- 3 July 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 34 (10) , 1106-1109
Challenging surgery of giant right coronary aneurysm associated with coronary sinus fistula
Coronary artery fistula is a rare congenital or acquired anomaly. It involves an abnormal connection between the coronary artery and the cardiac chambers or the large thoracic vessels. In some cases, the feeding coronary artery can become extremely dilated. The treatment includes a transcatheter or a surgical intervention depending on the complexity of the anomaly. We present the surgical treatment of the coronary artery to coronary sinus fistula, which includes the complete exclusion of the giant right coronary artery and followed by triple bypass surgery.
- 3 July 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 34 (10) , 1106-1109
Challenging surgery of giant right coronary aneurysm associated with coronary sinus fistula
Coronary artery fistula is a rare congenital or acquired anomaly. It involves an abnormal connection between the coronary artery and the cardiac chambers or the large thoracic vessels. In some cases, the feeding coronary artery can become extremely dilated. The treatment includes a transcatheter or a surgical intervention depending on the complexity of the anomaly. We present the surgical treatment of the coronary artery to coronary sinus fistula, which includes the complete exclusion of the giant right coronary artery and followed by triple bypass surgery.
- 24 April 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 34 (6) , 435-439
The role of ministernotomy in aortic valve surgery—A prospective randomized study
Background and Aims The purpose of this prospective randomized study was to compare the early and midterm outcomes of aortic valve replacement (AVR) through upper ministernotomy with conventional AVR through median sternotomy. Methods One hundred patients undergoing elective AVR were randomized into two groups: the M group (upper ministernotomy group, n = 50) and the C group (conventional sternotomy group, n = 50). The operative data, major adverse outcomes, and postoperative variables were compared between the two groups of patients. A cross‐sectional follow‐up was performed 24.9 ± 5.8 months after surgery. Results The aortic cross‐clamp time and cardiopulmonary bypass time were significantly longer in the M group. Similar incidences of major cardiac, neurologic and renal complications were recorded in both groups. Two patients (4%) in the C group developed wound infections. The length of ICU stay was similar in both groups. The patients in the M group had a shorter hospital stay compared with the patients in the C group (7.6 ± 2 days vs 9.3 ± 4.8 days; P = 0.022). Follow‐up revealed that the time period needed to reach full recovery was significantly shorter in the ministernotomy group (1.7 ± 1.2 months vs 2.8 ± 1.6 months; P = 0.001). Morbidity and mortality data did not differ between the two groups. Conclusions There was no difference in the major outcomes between the patients who underwent upper ministernotomy and those who underwent full sternotomy. The benefits of the minimally invasive approach were the shorter hospital stay and significantly faster recovery of patients after discharge from the hospital.
- 24 April 2019
- Published by Wiley in Journal of Cardiac Surgery
- Vol. 34 (6) , 435-439
The role of ministernotomy in aortic valve surgery—A prospective randomized study
Background and Aims The purpose of this prospective randomized study was to compare the early and midterm outcomes of aortic valve replacement (AVR) through upper ministernotomy with conventional AVR through median sternotomy. Methods One hundred patients undergoing elective AVR were randomized into two groups: the M group (upper ministernotomy group, n = 50) and the C group (conventional sternotomy group, n = 50). The operative data, major adverse outcomes, and postoperative variables were compared between the two groups of patients. A cross‐sectional follow‐up was performed 24.9 ± 5.8 months after surgery. Results The aortic cross‐clamp time and cardiopulmonary bypass time were significantly longer in the M group. Similar incidences of major cardiac, neurologic and renal complications were recorded in both groups. Two patients (4%) in the C group developed wound infections. The length of ICU stay was similar in both groups. The patients in the M group had a shorter hospital stay compared with the patients in the C group (7.6 ± 2 days vs 9.3 ± 4.8 days; P = 0.022). Follow‐up revealed that the time period needed to reach full recovery was significantly shorter in the ministernotomy group (1.7 ± 1.2 months vs 2.8 ± 1.6 months; P = 0.001). Morbidity and mortality data did not differ between the two groups. Conclusions There was no difference in the major outcomes between the patients who underwent upper ministernotomy and those who underwent full sternotomy. The benefits of the minimally invasive approach were the shorter hospital stay and significantly faster recovery of patients after discharge from the hospital.
- Open Access
- 8 March 2018
- Published by David Publishing Company in Journal of Pharmacy and Pharmacology
- Vol. 6 (3)
Postoperative Complications and Patient’s Satisfaction after Harvesting of the Radial Artery for Coronary Artery Bypass
- 8 March 2018
- Published by David Publishing Company in Journal of Pharmacy and Pharmacology
- Vol. 6 (3)
Open AccessPostoperative Complications and Patient’s Satisfaction after Harvesting of the Radial Artery for Coronary Artery Bypass
- 5 January 2017
- Published by SAGE Publications in Angiology
- Vol. 68 (9) , 790-794
Preoperative Insight Into the Quality of Radial Artery Grafts
We investigated the impact of preoperative ultrasonography of the forearm circulation on radial artery conduit selection. Preoperative ultrasound of the forearm circulation was performed routinely in 536 patients planned for radial artery harvesting. The safety assessment of the harvest included the following algorithm of tests: the ultrasound, the Allen test, and pulse oximetry. The quality criteria that were used to exclude a radial artery from harvesting were small size of the artery, diffuse atherosclerosis, calcifications, and severe neointimal hyperplasia. The overall rejection rate due to safety reasons was 16.4%. Seventy-one (13.2%) radial arteries did not fulfill the conduit quality criteria and consequently these arteries were not harvested. In 13.4% of radial arteries, localized arterial wall disease was found in the distal third of the artery. The distal part of the artery was discarded and the rest was used as a conduit. Our results indicate that the ultrasound provides an accurate preoperative insight into the radial artery morphology, enabling selection of the arteries with favorable morphological features.
- 5 January 2017
- Published by SAGE Publications in Angiology
- Vol. 68 (9) , 790-794
Preoperative Insight Into the Quality of Radial Artery Grafts
We investigated the impact of preoperative ultrasonography of the forearm circulation on radial artery conduit selection. Preoperative ultrasound of the forearm circulation was performed routinely in 536 patients planned for radial artery harvesting. The safety assessment of the harvest included the following algorithm of tests: the ultrasound, the Allen test, and pulse oximetry. The quality criteria that were used to exclude a radial artery from harvesting were small size of the artery, diffuse atherosclerosis, calcifications, and severe neointimal hyperplasia. The overall rejection rate due to safety reasons was 16.4%. Seventy-one (13.2%) radial arteries did not fulfill the conduit quality criteria and consequently these arteries were not harvested. In 13.4% of radial arteries, localized arterial wall disease was found in the distal third of the artery. The distal part of the artery was discarded and the rest was used as a conduit. Our results indicate that the ultrasound provides an accurate preoperative insight into the radial artery morphology, enabling selection of the arteries with favorable morphological features.
- 1 August 2014
- Published by Texas Heart Institute Journal in Texas Heart Institute Journal
- Vol. 41 (4) , 418-420
Cor Triatriatum Dexter and Atrial Septal Defect in a 43-Year-Old Woman
Cor triatriatum dexter is a rare congenital heart anomaly in which a membrane divides the right atrium into 2 chambers. We report the case of a 43-year-old woman who had cor triatriatum dexter and a large atrial septal defect. During attempted percutaneous closure, the balloon disrupted the membrane and revealed that the defect had no inferior rim, precluding secure placement of an Amplatzer Septal Occluder. Surgical treatment subsequently proved to be successful. In patients with an incomplete membrane and a septal defect with well-defined rims, percutaneous treatment can be the first choice. In patients who have cor triatriatum dexter and unfavorable anatomic features or concomitant complex heart anomalies, open-heart surgery remains the gold standard for treatment.
- 1 August 2014
- Published by Texas Heart Institute Journal in Texas Heart Institute Journal
- Vol. 41 (4) , 418-420
Cor Triatriatum Dexter and Atrial Septal Defect in a 43-Year-Old Woman
Cor triatriatum dexter is a rare congenital heart anomaly in which a membrane divides the right atrium into 2 chambers. We report the case of a 43-year-old woman who had cor triatriatum dexter and a large atrial septal defect. During attempted percutaneous closure, the balloon disrupted the membrane and revealed that the defect had no inferior rim, precluding secure placement of an Amplatzer Septal Occluder. Surgical treatment subsequently proved to be successful. In patients with an incomplete membrane and a septal defect with well-defined rims, percutaneous treatment can be the first choice. In patients who have cor triatriatum dexter and unfavorable anatomic features or concomitant complex heart anomalies, open-heart surgery remains the gold standard for treatment.
- 1 January 2013
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 66 (1-2) , 64-69
Heart surgery in patients on chronic dialysis
Introduction. Patients on dialysis for end-stage renal failure are subjected to cardiac surgery with increasing frequency. End-stage renal failure is known to be an important risk factor for complications of cardiac operations performed with cardiopulmonary bypass. The aim of this study was to determine the impact of preoperative clinical status and operative variables on perioperative morbidity and mortality in hemodialysis dependent patients subjected to a cardiac surgery. Material and Methods. The following operative variables were examined: urgency, type and duration of surgery and duration of extracorporeal circulation. The study is a retrospective analysis of consecutive patients with end-stage renal failure dependent on maintenance hemodialysis who underwent cardiac surgery during four years. Results. The study included 46 patients. Operations performed included isolated coronary artery bypass grafting (CABG, n = 24), valve surgery alone (n = 6), and combined valve surgery or coronary artery bypass grafting and valve surgery (n = 16). The perioperative mortality rate was 13% with four fatal outcomes in patients who had undergone combined cardiac surgery. We found age > 70 years, preoperative New York Heart Association class IV, preoperative anemia, combined surgery and emergent surgery to be associated with a higher relative risk for perioperative death. Conclusion. Patients on dialysis have an increased morbidity and mortality following cardiac surgery; however, we believe that end-stage renal failure should not be regarded as a contraindication to cardiac surgery or cardiopulmonary bypass.
- 1 January 2013
- Published by National Library of Serbia in Medicinski Pregled
- Vol. 66 (1-2) , 64-69
Heart surgery in patients on chronic dialysis
Introduction. Patients on dialysis for end-stage renal failure are subjected to cardiac surgery with increasing frequency. End-stage renal failure is known to be an important risk factor for complications of cardiac operations performed with cardiopulmonary bypass. The aim of this study was to determine the impact of preoperative clinical status and operative variables on perioperative morbidity and mortality in hemodialysis dependent patients subjected to a cardiac surgery. Material and Methods. The following operative variables were examined: urgency, type and duration of surgery and duration of extracorporeal circulation. The study is a retrospective analysis of consecutive patients with end-stage renal failure dependent on maintenance hemodialysis who underwent cardiac surgery during four years. Results. The study included 46 patients. Operations performed included isolated coronary artery bypass grafting (CABG, n = 24), valve surgery alone (n = 6), and combined valve surgery or coronary artery bypass grafting and valve surgery (n = 16). The perioperative mortality rate was 13% with four fatal outcomes in patients who had undergone combined cardiac surgery. We found age > 70 years, preoperative New York Heart Association class IV, preoperative anemia, combined surgery and emergent surgery to be associated with a higher relative risk for perioperative death. Conclusion. Patients on dialysis have an increased morbidity and mortality following cardiac surgery; however, we believe that end-stage renal failure should not be regarded as a contraindication to cardiac surgery or cardiopulmonary bypass.
- 5 December 2012
- Published by SAGE Publications in Angiology
- Vol. 64 (1) , 80-81
Evaluation of Radial Artery Atherosclerosis by Intravascular Ultrasound
- 5 December 2012
- Published by SAGE Publications in Angiology
- Vol. 64 (1) , 80-81
Evaluation of Radial Artery Atherosclerosis by Intravascular Ultrasound
- 1 November 2010
- Vol. 19 (6) , 803-5
Repair of hammock mitral valve with hypoplastic posterior leaflet in an adult.
Congenital hammock mitral valves are rarely discovered in adulthood. The case is presented of a 29-year-old woman in NYHA functional class III and with markedly depressed left ventricular (LV) function, who underwent surgery for severe mitral regurgitation. Preoperative transthoracic echocardiography showed grade 3+/4 mitral regurgitation due to restricted leaflet motion, and an almost immobile posterior leaflet due to the attachment of fibrotic chordae high on the posterior LV wall. At surgery, limited motion of both leaflets and partial agenesis of the posterior leaflet were found. The valve was repaired by resecting the posterior leaflet defect, mobilizing the papillary muscle, and then widening the posterior leaflet. Postoperative echocardiography revealed no further mitral regurgitation, and the valve remained competent despite a postoperative episode of cardiac decompensation. Hammock mitral valve repair is a highly challenging procedure, particularly in patients presenting with LV dilatation. The greatest degree of leaflet mobility must be restored in order to prevent tethering. Thus, it is strongly recommended that the posterior leaflet is systematically widened, even in the presence of an apparently large leaflet surface.
- 1 November 2010
- Vol. 19 (6) , 803-5
Repair of hammock mitral valve with hypoplastic posterior leaflet in an adult.
Congenital hammock mitral valves are rarely discovered in adulthood. The case is presented of a 29-year-old woman in NYHA functional class III and with markedly depressed left ventricular (LV) function, who underwent surgery for severe mitral regurgitation. Preoperative transthoracic echocardiography showed grade 3+/4 mitral regurgitation due to restricted leaflet motion, and an almost immobile posterior leaflet due to the attachment of fibrotic chordae high on the posterior LV wall. At surgery, limited motion of both leaflets and partial agenesis of the posterior leaflet were found. The valve was repaired by resecting the posterior leaflet defect, mobilizing the papillary muscle, and then widening the posterior leaflet. Postoperative echocardiography revealed no further mitral regurgitation, and the valve remained competent despite a postoperative episode of cardiac decompensation. Hammock mitral valve repair is a highly challenging procedure, particularly in patients presenting with LV dilatation. The greatest degree of leaflet mobility must be restored in order to prevent tethering. Thus, it is strongly recommended that the posterior leaflet is systematically widened, even in the presence of an apparently large leaflet surface.
- 4 October 2010
- Published by SAGE Publications in Perfusion
- Vol. 26 (1) , 31-37
Steroids and statins: an old and a new anti-inflammatory strategy compared
Objectives: This study compared the anti-inflammatory effects of methylprednisolone (MP) and atorvastatin and analysed their influences on clinical variables in patients undergoing coronary revascularization. Methods: Ninety patients with compromised left ventricular ejection fraction (≤30%) undergoing elective coronary surgery were equally randomized to one of three groups: statin group, treatment with atorvastatin (20 mg/day) 3 weeks before surgery; methylprednisolone group, a single shot of methylpredniosolone (10mg/kg); and control group. Results: Postoperative IL-6 was higher in the control group when compared to the methylprednisolone and statin groups (p<0.01). IL-6 was higher in the statin-treated patients (p<0.05 versus methylprednisolone). Administration of methylprednisolone as well as statin treatment increased postoperative cardiac index, left ventricular stroke work index, decreased postoperative atrial fibrilation rate and reduced ICU stay (p<0.05 versus control). The number of patients requiring inotropic support was lower in the methylprednisolone group when compared with the other two groups (p<0.01). Tracheal intubation time was reduced in patients who received methylprednisolone (p<0.01 versus control). Conclusions: Preoperative administration of either methylprednisolone or atorvastatin reduced pro-inflammatory cytokine release, improved haemodynamics, decreased postoperative atrial fibrilation rate and reduced ICU stay in patients with significantly impaired cardiac function undergoing coronary revascularization. Treatment with methylprednisolone was associated with less inotropic support requirements and reduced mechanical ventilation time.
- 4 October 2010
- Published by SAGE Publications in Perfusion
- Vol. 26 (1) , 31-37
Steroids and statins: an old and a new anti-inflammatory strategy compared
Objectives: This study compared the anti-inflammatory effects of methylprednisolone (MP) and atorvastatin and analysed their influences on clinical variables in patients undergoing coronary revascularization. Methods: Ninety patients with compromised left ventricular ejection fraction (≤30%) undergoing elective coronary surgery were equally randomized to one of three groups: statin group, treatment with atorvastatin (20 mg/day) 3 weeks before surgery; methylprednisolone group, a single shot of methylpredniosolone (10mg/kg); and control group. Results: Postoperative IL-6 was higher in the control group when compared to the methylprednisolone and statin groups (p<0.01). IL-6 was higher in the statin-treated patients (p<0.05 versus methylprednisolone). Administration of methylprednisolone as well as statin treatment increased postoperative cardiac index, left ventricular stroke work index, decreased postoperative atrial fibrilation rate and reduced ICU stay (p<0.05 versus control). The number of patients requiring inotropic support was lower in the methylprednisolone group when compared with the other two groups (p<0.01). Tracheal intubation time was reduced in patients who received methylprednisolone (p<0.01 versus control). Conclusions: Preoperative administration of either methylprednisolone or atorvastatin reduced pro-inflammatory cytokine release, improved haemodynamics, decreased postoperative atrial fibrilation rate and reduced ICU stay in patients with significantly impaired cardiac function undergoing coronary revascularization. Treatment with methylprednisolone was associated with less inotropic support requirements and reduced mechanical ventilation time.